Skip to content
EN
EN FR NL
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Menu
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Menu
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Donate
BIG Members
EN
EN FR NL

2022

First results from POSITIVE study: Young women with breast can safely have a baby

World Cancer Day 2022: the DECRESCENDO study

OlympiA trial – olaparib reduces risk of death by 32% in patients with a specific breast cancer profile

Eight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer

Pink October 2022 – BIG Missing Campaign

BIG-supported-by-BIG-against-bc-logo

Breast International Group (BIG) – aisbl

Facebook-f Twitter Instagram Linkedin Youtube Flickr

Head Office

  • Rue de Bretagne 20, 1200 Brussels, Belgium
  • +32 2 486 16 00
  • VAT BE 0468 176 240
  • IBAN BE08 0689 0916 0213

Tax Deduction

Donations greater than or equal to € 40 / year receive a 45% tax reduction. This means your donation of €40 only costs you € 22.

Site Links

  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
AERFLABELPMSDEFVblanc

The Breast International Group is proud to adhereto the Code of Ethics of the VEF-AERF

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

â’¸ 2023- All Rights Are Reserved